Home › Multiple Myeloma › California › Newport Beach
Multiple Myeloma clinical trials in Newport Beach, CA
3 studies for Multiple Myeloma are looking for participants at sites in and around Newport Beach (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
RecruitingPhase 2
- City of Hope at Newport Beach Fashion Island, Newport Beach
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
RecruitingPhase 1/2
- Hoag Family Cancer Center, Newport Beach
A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients
RecruitingObservational studyHealthy volunteers welcome
- City of Hope at Newport Beach Fashion Island, Newport Beach
About Multiple Myeloma
Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. Discover symptoms, diagnostic tests, and treatments for myeloma.
More about Multiple Myeloma on MedlinePlus
Multiple Myeloma trials in other cities
- New York City, NY60 studies
- Boston, MA42 studies
- Atlanta, GA41 studies
- Houston, TX38 studies
- Durham, NC37 studies
- Nashville, TN32 studies
- Denver, CO27 studies
- Rochester, MN24 studies
- St. Louis, MO24 studies
- Columbus, OH24 studies
- Baldwin Park, CA23 studies
- Chicago, IL22 studies
Other studies in Newport Beach
- Breast Cancer16 studies
- Non-Small Cell Lung Cancer14 studies
- Metastatic Cancer10 studies
- Ovarian Cancer9 studies
- COPD8 studies
- Endometrial Cancer7 studies
- Lung Cancer7 studies
- Cancer (all types)6 studies
- Prostate Cancer6 studies
- Triple-Negative Breast Cancer6 studies
- Colorectal Cancer6 studies
- Kidney Cancer (Renal Cell Carcinoma)5 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.